Incubation of chicken embryo fibroblasts with mitogenic concentrations of insulin for 24 hr or with the tumor promoter phorbol 12-myristate 13-acetate for 6 hr stimulated lactate release and 3-0-methylglucose uptake. Insulin also increased the V.. of 6-phosphofructo-1-kinase
2,6-bisphosphate concentration did not decrease after cyclic AMP treatment. Incubation of cells with phorbol ester analogues or with glycerol derivatives that are known to stimulate, or to bind to, protein kinase C did increase the concentration of fructose 2,6-bisphosphate, suggesting that the stimulation of 6-phosphofructo-2-kinase by phorbol 12-myristate 13-acetate is mediated by protein kinase C.
A biochemical characteristic of many tumors and of established lines of transformed cells is their high rate of aerobic glycolysis (1, 2) . A stimulation of glycolysis can also be observed following exposure of quiescent cells to growth factors (3, 4) and tumor promoters such as phorbol esters (5, 6) . The mechanism of this stimulation is unknown.
The most potent endogenous stimulator of 6-phosphofructo-1-kinase (PFK-1; ATP: D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11), one of the key enzymes of glycolysis, is fructose 2,6-bisphosphate (Fru-2,6-P2). In liver, the kinetics of PFK-1 are such that its activity is negligible at physiological concentrations of substrates, and Fru-2,6-P2 relieves the inhibition exerted by ATP, thus allowing glycolysis to proceed. Fru-2,6-P2 also inhibits the gluconeogenic enzyme fructose-1,6-bisphosphatase (D-fructose-1-6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11). Both of these effects are synergistic with those of AMP. Fru-2,6-P2 is synthesized from fructose 6-phosphate and ATP by a 6-phosphofructo-2-kinase (PFK-2; EC 2.7.1.-); it is hydrolyzed to fructose 6-phosphate and Pi by a fructose-2,6-bisphosphatase (EC 3.1.3.-). Both activities are borne by the same protein and are regulated by the cyclic AMP-dependent protein kinase (ATP:protein phosphotransferase, EC 2.7.1.37); phosphorylation inactivates PFK-2 and activates fructose-2,6-bisphosphatase (for a review, see refs. [7] [8] [9] .
Fru-2,6-P2 has been identified in all mammalian cells studied so far, except erythrocytes (8) . Evidence has been presented for its involvement in the control of glycolysis by glucose and hormones in rat liver (8, 10) , heart and skeletal muscle (11) (12) (13) , white adipose tissue (14) , pancreatic islets (15) , hepatoma cells (16) , and Ehrlich ascites tumor (17) . We have now examined whether Fru-2,6-P2 might also play a role in the control ofglycolysis by mitogens and tumor promoters. This hypothesis has been tested in chicken embryo fibroblasts exposed to mitogenic concentrations of insulin and to the tumor promoter phorbol 12-myristate 13-acetate (PMA). Indeed, insulin and phorbol esters stimulate glycolysis and glucose transport in fibroblasts (5, 6, 18, 19) . Moreover, the stimulation of glycolysis by insulin in human fibroblasts is accompanied by an increase in Fru-2,6-P2 (18) .
MATERIALS AND METHODS
Cell Cultures. Primary cultures of chicken embryo fibroblasts prepared (20) from 8-to 9-day-old embryos (White Leghorn, Lohman, Cuxhaven, FRG) were maintained at 38°C for 4 days in an atmosphere 94% air/6% CO2. The cells were then collected by trypsinization followed by centrifugation, and resuspended in growth medium (F10 medium from Flow Laboratories enriched with 5% newborn calf serum/10% tryptose phosphate broth/7 mM NaHCO3). Plastic Petri dishes (60 mmi and 100 mm diameter) were seeded with 0.7 and 2 x 106 cells, respectively. After 4 days of secondary culture, the growth medium was removed and replaced by 5 ml (60-mm dish) or 10 ml (100-mm dish) of incubation medium (126 mM NaCl/14 mM NaHCO3/3.8 mM KC1/0.9 mM Na2HPO4/0.6 mM KH2PO4/0.6 mM MgSO4/0.3 mM CaCl2/6 mM glucose/20 mM Hepes, pH 7.2). Porcine insulin (monocomponent, NOVO Industri, Copenhagen), phorbol esters, or glycerol derivatives (Sigma) were added at the indicated concentrations; the controls received the corresponding volume of the vehicle [0.15 M NaCl for insulin; 0.01% (vol/vol) dimethyl sulfoxide for PMA].
Measurement of Metabolites. To obtain deproteinized cell extracts, the incubation medium was rapidly aspirated and 1 ml of 50 mM NaOH containing 1% (vol/vol) Triton X-100 (for the measurement of Fru-2,6-P2) or 0.5 ml of 0.5 M perchloric acid (for the measurement of other metabolites) was added at 0°C to the cell layer. The plates were scraped with a plastic spatula and the alkali extracts were heated for 10 min at 80°C; the acid extracts were centrifuged (15 min, Eppendorf microfuge) and the supernates were neutralized with saturated K2CO3. Glucose 6-phosphate, fructose 6?phosphate, fructose 1,6-bisphosphate, Fru-2,6-P2, and lactate were measured as described (13 (14) were measured under Vmax conditions. One unit of enzyme activity is the amount of enzyme that catalyzes the formation of one ,umol of product per min under the assay conditions. Proteins were measured as described (23) . One milligram of cellular protein corresponds to -11 mg of cells.
Measurement of 3-O-Methylglucose Uptake. The uptake of 3-O-methylglucose was measured essentially as described (24) . After incubation with insulin or PMA, the cells were washed three times with 10 ml of Dulbecco's modified phosphate-buffered saline (24) and exposed in the latter buffer for 30 sec at 22°C to 10 mM 3-O-[methyl-14C]glucose (1.5 ,uCi/ml; 1 Ci = 37 GBq) and 10 mM L-[3H]glucose (1.5 ,uCi/ml). The latter was used to measure the rate of diffusion.
The rate of uptake was linear for at least 60 sec. At the end of the incubation, the buffer was quickly aspirated and 10 ml of ice-cold buffer containing 0.1 mM phloretin but no glucose was added. The buffer was removed and the cell layer was washed twice with cold buffer. Finally, the cells were suspended in 1 ml of 0.1 M NaOH containing 0.1% (wt/vol) NaDodSO4, and 0.2-ml samples were taken to measure the radioactivity. The rates of uptake of 3-O-methylglucose were corrected for the rate of diffusion of radioactive L-glucose within the same sample.
RESULTS
Fru-2,6-P2 Concentration and Glycolytic Flux. Under basal conditions-i.e., with 6 mM glucose-the average rate of lactate release was 8 ± 0. As shown in Fig. 1 , lactate release increased not only in the presence of insulin, as expected from work on mammalian fibroblasts (18) , but also after exposure of the cells to PMA. The rate of lactate release measured under steady-state conditions of stimulation increased =2-fold after insulin treatment and =3-fold after PMA treatment.
We then determined whether Fru-2,6-P2 is present in chicken embryo fibroblasts and, if so, whether it is controlled by insulin and PMA. As seen in Fig. 1 , Fru-2,6-P2 was detectable in these cells where its concentration was =25 pmol per mg of protein under steady-state conditions of incubation. After insulin addition (Fig. LA) , an increase in the concentration of Fru-2,6-P2 was detectable at 2 hr and plateaued (3-to 4-fold increase) after 10 hr. The insulin effects on both lactate release and Fru-2,6-P2 were much smaller (10-20% increase) when the cells used for incubation were taken from confluent monolayers. PMA treatment also led to an increase in Fru-2,6-P2 concentration, which was detectable after 1 hr of incubation (Fig. 1B) . The effect was larger, with a maximum at 3-6 hr (4-to 5-fold increase) that did not persist for as long as with insulin. When cells were synchronized by serum starvation for 4 days (25), and serum was then added to resume the cell cycle, PMA increased Fru-2,6-P2 concentration when added 2 or 14 hr after the serum, indicating that this effect was independent of the cell cycle. It is noteworthy that the changes in Fru-2,6-P2 induced by insulin or PMA preceded the stimulation of lactate release (Fig. 1 ).
Dose-response curves for the effects of insulin after 24 hr are shown in Fig. 2A . Half-maximal effects on Fru-2,6-P2 concentration and lactate release were obtained at different concentrations (i.e., =10 nM and =1 nM insulin, respectively). Nearly maximal effects on lactate release were obtained at doses of insulin that had little effect on Fru-2,6-P2. Insulin at concentrations <1 nM had no effect on Fru-2,6-P2 even when the hormone was added every 6 hr during the 24-hr incubation. Fig. 2A also shows that, with insulin concentrations >400 nM, the concentration of Fru-2,6-P2 fell below control values, while lactate release remained at the basal level. This phenomenon might result from the dimerization of insulin molecules, which is known to occur at concentrations >200 nM (26) . Dose-response curves for the effect of PMA on lactate release and Fru-2,6-P2 concentration were constructed from data obtained after 4 hr of treatment (Fig. 2B) . In contrast to the effects of insulin, half-maximal effects on To explore the mechanism of Fru-2,6-P2 increase, we examined whether PFK-2, the enzyme that catalyzes the synthesis of Frus-2,6-P2, was influenced by insulin or PMA.
We found that, indeed, the activity of PFK-2 was 1.5-fold greater 24 hr after exposure to 170 nM insulin ( GMP, or 0.5 AM dexamethasone did not affect the concentration of Fru-2,6-P2, whether insulin was present or not (results not shown). When the concentration ofglucose in the incubation medium was increased to 25 mM, the concentration of Fru-2,6-P2 measured after 24 hr of incubation increased from 28 ± 1 pmol per mg of protein to 54 ± 1 pmol per mg of protein, a concentration that was not further enhanced by 170 nM insulin. This suggests that both glucose and insulin increase Fru-2,6-P2 concentration by increasing PFK-2 activity.
Effect of Phorbol Analogues and Glycerol Derivatives on Fru-2,6-P2. Since PMA is known to stimulate protein kinase C activity by mimicking endogenous diacylglycerol (27) , we explored the ability of several phorbol analogues and glycerol derivatives to increase Fru-2,6-P2 concentration. The results (Table 1) show that phorbol analogues such as nonesterified a and 13 phorbol anomers and phorbol 12,13,20-triacetate, which are known to be ineffective in stimulating protein kinase C activity (28), did not affect Fru-2,6-P2. By contrast, glycerol derivatives such as oleoylacetylglycerol, dicaproin, and dicaprylin, which are known to stimulate and/or to bind to protein kinase C, did also increase the concentration of Fru-2,6-P2. All the other compounds (phospholipids) tested were active except dipalmitoyl and dimyristoyl phosphatidic acid.
Stimulation of PFK-1 by Fru-2,6-P2. Having found that Fru-2,6-P2 is present in chicken embryo fibroblasts and that its concentration is increased by insulin and PMA, we next studied whether the PFK-1 partially purified from these cells was sensitive to Fru-2,6-P2, as is the case in other tissues.
Since this sensitivity depends on other effectors such as Pi, NH+, AMP, and ATP, experimental conditions were chosen to mimic their intracellular concentration (29) . The results (Fig. 4) show that PFK-1 activity was sensitive to Fru-2,6-P2 depending on the concentration of fructose 6-phosphate. At physiological concentrations of fructose 6-phosphate (0.5 mM or below), Fru-2,6-P2 was required for PFK-1 activity to be expressed, with a half-maximal effect at 3.5 uM Fru-2,6-P2. The latter value falls within the very range of Fru-2,6-P2 concentrations actually measured in the intact cells-i.e., from 2.5 nmol/g under basal conditions to 15 nmol/g after PMA addition.
Glucose Uptake and Concentration of Hexose Phosphates. In view of earlier work (5, 19) , the effect of insulin and PMA on glucose uptake was studied by measuring 3-O-methylglucose uptake at different times after the addition of these agents (Table 2) . Under control conditions, the apparent Km for Cells were exposed to the agents listed for 4.5 hr in incubation medium supplemented with 1 mg of fatty acid-free bovine serum albumin per ml. The concentration of all glycerol derivatives was 100 Ag/ml. Values are means ± SD for three incubations. Consistent with the stimulation of glucose uptake by insulin, the concentration of hexose 6-phosphates almost doubled, whereas that of fructose 1,6-bisphosphate was increased by only 30% in cells incubated for 24 hr with insulin ( Table 3 ). The smaller effect on fructose 1,6-bisphosphate than on hexose 6-phosphates might indicate that this metabolite is readily used by the enzymes further down the glycolytic pathway and that the reactions catalyzed by these enzymes are not rate-limiting. The increase in the concentration of fructose 6-phosphate, a substrate of both PFK-2 and PFK-1, might explain, at least in part, the increase in both the concentration of Fru-2,6-P2 and the glycolytic flux. The latter interpretation does not hold true for PMA, which, in contrast to insulin, did not increase the concentration of hexose 6-phosphates. 
DISCUSSION
The data presented show that glycolysis in chicken embryo fibroblasts is stimulated by insulin and by a tumor promoter such as PMA. With the finding that Fru-2,6-P2 is influenced by mitogenic concentrations of insulin and by PMA in chicken embryo fibroblasts, we have identified a mechanism for the control of glycolysis by mitogens and phorbol esters.
Our results suggest at least three ways in which insulin controls glycolysis in chicken embryo fibroblasts. First, it stimulates glucose uptake. Second, it increases PFK-2 activity, thereby providing more Fru-2,6-P2 for the stimulation of PFK-1. Third, it increases the Vma of PFK-1. Yet, this increased activity of PFK-1 is not sufficient to keep pace with the increased glucose uptake, hence the accumulation of hexose 6-phosphates. The fact that insulin stimulated glucose uptake and lactate release at concentrations that were without effect on Fru-2,6-P2 may indicate that insulin acts via two types of receptors. Indeed, the mitogenic action of insulin in human fibroblasts does not appear to be mediated by the classical insulin receptor (30) . In addition to the latter, chicken embryo fibroblasts possess a receptor for growth peptides (31) to which insulin binds with an affinity (Kd '50 x 10-9 M) corresponding to the concentrations of insulin that are active on Fru-2,6-P2 in our system. Therefore, insulin could act on the Fru-2,6-P2 system via this low-affinity receptor and on glucose uptake via both types of receptors.
The stimulation of glycolysis by PMA is also associated with an activation of both glucose uptake and PFK-2, leading to a large increase in Fru-2,6-P2 concentration. This, in turn, causes a stimulation of PFK-1 to a point sufficient to prevent any accumulation of hexose 6-phosphates resulting from the increased rate of glucose transport. Consistent with a key role of the PFK-2/Fru-2,6-P2 system in the control of glycolysis by PMA is the fact that half-maximal increases in lactate release and Fru-2,6-P2 concentration were obtained with the same concentrations of PMA.
Phorbol esters exert pleiotropic effects on growth, function, and differentiation in a variety of cells (32, 33) . Some of these effects, including protein phosphorylation, occur within minutes (33) (34) (35) (36) (37) ; others take hours to develop (19, 32, 38) , a time course reminiscent of that observed for the stimulation of glycolysis by PMA. Since the most likely target of phorbol esters is protein kinase C (33), we speculate that this kinase can activate PFK-2 directly or indirectly. This is supported by the analogy between the effects of phorbol ester analogues and glycerol derivatives on Fru-2,6-P2 concentration and their known effects on protein kinase C (27, 28) . Since the phosphorylation state of PFK-2 is not affected by PMA in isolated rat hepatocytes (37) , the regulation of the PFK-2 system could be different in chicken embryo fibroblasts, consistent with our finding that it is resistant to cyclic AMP.
Our studies provide an original case for the stimulation of an intracellular enzyme activity, PFK-2, by both a tumor promoter and a mitogen. This enzyme activity could account for the high rate of aerobic glycolysis that is characteristic of many tumors.
